在家使用四晚MD-Logic人工胰腺（DREAM4）后，低血糖担忧减轻、满意度高且感知易用性增强。
Reduced Worries of Hypoglycaemia, High Satisfaction, and Increased Perceived Ease of Use after Experiencing Four Nights of MD-Logic Artificial Pancreas at Home (DREAM4).
作者信息
Ziegler Claudia, Liberman Alon, Nimri Revital, Muller Ido, Klemenčič Simona, Bratina Nataša, Bläsig Sarah, Remus Kerstin, Phillip Moshe, Battelino Tadej, Kordonouri Olga, Danne Thomas, Lange Karin
机构信息
Diabetes Centre for Children and Adolescents, Kinder- und Jugendkrankenhaus AUF DER BULT, 30173 Hannover, Germany.
The Jesse Z and Sara Lea Shafer Institute for Endocrinology and Diabetes, National Center for Childhood Diabetes, Schneider Children's Medical Center of Israel, 49202 Petah Tikva, Israel.
出版信息
J Diabetes Res. 2015;2015:590308. doi: 10.1155/2015/590308. Epub 2015 Oct 25.
AIMS
This study assesses the impact of using an AP-system at home on fear of hypoglycaemia. In addition, satisfaction and acceptance of the new technology are evaluated.
METHODS
In a multicentre, multinational study of 75 patients using the MD-Logic AP during four consecutive nights in home setting 59 of them (aged 10-54 years, 54% male, HbA1c 7.89 ± 0.69% [62.72 ± 7.51 mmol/mol], diabetes duration 11.6 ± 8.4 yrs) answered standardized questionnaires (HFS, adapted TAM, and AP satisfaction) before and after using the AP.
RESULTS
After experiencing the AP in home setting worries of hypoglycaemia were significantly reduced (before 1.04 ± 0.53 versus after 0.90 ± 0.63; P = 0.017). Perceived ease of use as a measure of acceptance with the AP significantly increased after personal experience (before 4.64 ± 0.94 versus after 5.06 ± 1.09; P = 0.002). The overall satisfaction mean score after using the AP was 3.02 ± 0.54 (range 0-4), demonstrating a high level of satisfaction with this technology.
CONCLUSIONS
The four-night home-based experience of using MD Logic AP was associated with reduced worries of hypoglycaemia, high level of satisfaction, and increased perceived ease of use of the new technology in children, adolescents, and adults.
目的
本研究评估在家中使用自动胰岛素给药（AP）系统对低血糖恐惧的影响。此外，还对新技术的满意度和接受度进行评估。
方法
在一项多中心、跨国研究中，75名患者在家庭环境中连续四个晚上使用MD-Logic AP系统，其中59名患者（年龄10 - 54岁，男性占54%，糖化血红蛋白7.89±0.69%[62.72±7.51 mmol/mol]，糖尿病病程11.6±8.4年）在使用AP系统前后回答了标准化问卷（低血糖恐惧量表、改良技术接受模型和AP满意度问卷）。
结果
在家庭环境中体验AP系统后，低血糖担忧显著降低（使用前1.04±0.53，使用后0.90±0.63；P = 0.017）。个人体验后，作为对AP系统接受度衡量指标的感知易用性显著提高（使用前4.64±0.94，使用后5.06±1.09；P = 0.002）。使用AP系统后的总体满意度平均得分为3.02±0.54（范围0 - 4），表明对该技术的满意度较高。
结论
使用MD Logic AP系统进行的为期四晚的家庭体验与儿童、青少年和成人低血糖担忧的减少、高满意度以及新技术感知易用性的提高相关。
Zotero 插件